CD46 in a Spanish cohort of multiple sclerosis patients: Genetics, mRNA expression and response to interferon-beta treatment

Multiple Sclerosis Journal

Volumn 17, Issue 5, 2011, Pages 513-520

  Alvarez Lafuente, Roberto ^a   Blanco Kelly, Fiona ^a   Garcia Montojo, Marta ^a   Martínez, Alfonso ^a   De Las Heras, Virginia ^a   Dominguez Mozo, Maria Inmaculada ^a   Bartolome, Manuel ^a   Garcia Martinez, Angel ^a   De La Concha, Emilio Gomez ^a   Urcelay, Elena ^a   Arroyo, Rafael ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

CD46; Interferon beta; MRNA; Multiple sclerosis; RT PCR; SNP

Indexed keywords

BETA INTERFERON; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; CD46 PROTEIN, HUMAN; IMMUNOLOGIC FACTOR;

ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; TREATMENT RESPONSE; UPREGULATION; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; GENE FREQUENCY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; PATIENT SELECTION; PHARMACOGENETICS; RISK; TIME; TREATMENT OUTCOME;

ANTIGENS, CD46; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MULTIPLE SCLEROSIS; ODDS RATIO; PATIENT SELECTION; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPAIN; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 80053394440     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458510393263     Document Type: Article

References (20)

1. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA and Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999; 99: 817-827. (Pubitemid 30017651)
2. Alvarez-Lafuente R, De Las Heras V, Bartolome M, Garcia-Montojo M and Arroyo R. Human herpesvirus 6 and multiple sclerosis: A one-year follow-up study. Brain Pathol 2006; 16: 20-27.
3. Fotheringham J and Jacobson S. Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virusinduced disease. Herpes 2005; 12: 4-9. (Pubitemid 40863380)
4. Pietiläinen J, Virtanen JO, Uotila L, Salonen O, Koskiniemi M and FärkkiläM. HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis. Eur J Neurol 2009; DOI: 10.1111/j.1468-1331.2009.02718.x.
5. Fogdell-Hahn A, Soldan SS, Shue S, Akhyani N, Refai H, Ahlqvist J, et al. Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients. Virus Res 2005; 110: 57-63. (Pubitemid 40544546)
6. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM and Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421: 388-392. (Pubitemid 36157938)
7. Astier AL, Meiffren G, Freeman S and Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 2006; 116: 3252-3257. (Pubitemid 44878639)
8. Astier AL and Hafler DA. Abnormal Tr1 differentiation in multiple sclerosis. J Neuroimmunol 2007; 191: 70-78. (Pubitemid 350061001)
9. Vaknin-Dembinsky A, Balashov K and Weiner HL. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol 2006; 176: 7768-7774. (Pubitemid 43849078)
10. Vaknin-Dembinsky A, Murugaiyan G, Hafler DA, Astier AL and Weiner HL. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J Neuroimmunol 2008; 195: 140-145.
11. Shusta EV, Zhu C, Boado RJ and Pardridge WM. Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier. J Neuropathol Exp Neurol 2002; 61: 597-604. (Pubitemid 34721464)
12. Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, Dominguez-Mozo MI, Bartolome M and Arroyo R. CD46 expression and HHV-6 infection in patients with multiple sclerosis. Acta Neurol Scand 2009; 120: 246-250.
13. Waubant E, Goodkin DE, Gee L, Bacchetti P, Sloan R, Stewart T, et al. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 1999; 53: 1397-1401. (Pubitemid 29491927)
14. Yen JH, Kong W and Ganea D. IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J Immunol 2010; 184: 3478-3486.
15. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231. (Pubitemid 13158528)
16. McDonald WI, Fazekas F and Thompson AJ. [Diagnosis of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova 2003; 2: 4-9.
17. Pachner AR, Narayan K, Price N, Hurd M and Dail D. MxA gene expression analysis as an interferon-beta bioactivity measurement in patients with multiple sclerosis and the identification of antibody-mediated decreased bioactivity. Mol Diagn 2003; 7: 17-25. (Pubitemid 37339029)
18. Pollard AJ, Flanagan BF, Newton DJ and Johnson PM. A novel isoform of human membrane cofactor protein (CD46) mRNA generated by intron retention. Gene 1998; 212: 39-47. (Pubitemid 28269131)
19. Seya T, Hara T, Iwata K, Kuriyama S, Hasegawa T, Nagase Y, et al. Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera. Int Immunol 1995; 7: 727-736.
20. Szalmás A, Kónya J, Sziklai I and Karosi T. Detection and identification of CD46 splicing isoforms by nested RT-PCR. Methods Mol Biol 2010; 630: 83-95.